BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9029440)

  • 1. The effectiveness of 0.5% atropine in controlling high myopia in children.
    Chou AC; Shih YF; Ho TC; Lin LL
    J Ocul Pharmacol Ther; 1997 Feb; 13(1):61-7. PubMed ID: 9029440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for progressive myopia in the atropine therapy for myopia study.
    Loh KL; Lu Q; Tan D; Chia A
    Am J Ophthalmol; 2015 May; 159(5):945-9. PubMed ID: 25640408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cycloplegic effectiveness of cyclopentolate and tropicamide preparations compared with atropinization].
    Proskurina OV
    Vestn Oftalmol; 2002; 118(6):42-5. PubMed ID: 12506660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study.
    Fan DS; Lam DS; Chan CK; Fan AH; Cheung EY; Rao SK
    Jpn J Ophthalmol; 2007; 51(1):27-33. PubMed ID: 17295137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atropine 0.01% Eyedrops Significantly Reduce the Progression of Childhood Myopia.
    Clark TY; Clark RA
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):541-5. PubMed ID: 26218150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of myopia onset with 0.025% atropine in premyopic children.
    Fang PC; Chung MY; Yu HJ; Wu PC
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):341-5. PubMed ID: 20698798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
    Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D
    Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine.
    Tong L; Huang XL; Koh AL; Zhang X; Tan DT; Chua WH
    Ophthalmology; 2009 Mar; 116(3):572-9. PubMed ID: 19167081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of different concentrations of atropine on controlling myopia in myopic children.
    Shih YF; Chen CH; Chou AC; Ho TC; Lin LL; Hung PT
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):85-90. PubMed ID: 10048351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of topical atropine on intraocular pressure and myopia progression: a prospective comparative study.
    Lee CY; Sun CC; Lin YF; Lin KK
    BMC Ophthalmol; 2016 Jul; 16():114. PubMed ID: 27435576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%.
    Chia A; Chua WH; Wen L; Fong A; Goon YY; Tan D
    Am J Ophthalmol; 2014 Feb; 157(2):451-457.e1. PubMed ID: 24315293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of myopia progression with 0.05% atropine solution.
    Lee JJ; Fang PC; Yang IH; Chen CH; Lin PW; Lin SA; Kuo HK; Wu PC
    J Ocul Pharmacol Ther; 2006 Feb; 22(1):41-6. PubMed ID: 16503774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atropine versus cyclopentolate plus tropicamide in esodeviations.
    Goldstein JH; Schneekloth BB
    Ophthalmic Surg Lasers; 1996 Dec; 27(12):1030-4. PubMed ID: 8976523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term results of using low-concentration atropine eye drops for controlling myopia progression in schoolchildren.
    Wu PC; Yang YH; Fang PC
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):461-6. PubMed ID: 21815829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Changes in Refraction and Biometry of Atropine- and Placebo-Treated Eyes.
    Kumaran A; Htoon HM; Tan D; Chia A
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5650-5. PubMed ID: 26313301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of childhood myopia with atropine eyedrops and bifocal spectacles.
    Chiang MF; Kouzis A; Pointer RW; Repka MX
    Binocul Vis Strabismus Q; 2001; 16(3):209-15. PubMed ID: 11511288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effects of cyclopentolate and tropicamide eye drops on macular choroidal thickness in myopic children.
    Kobia-Acquah E; Flitcroft DI; Lingham G; Kerin E; Loughman J
    Ophthalmic Physiol Opt; 2024 Mar; 44(2):280-291. PubMed ID: 38037443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial.
    Yam JC; Zhang XJ; Zhang Y; Yip BHK; Tang F; Wong ES; Bui CHT; Kam KW; Ng MPH; Ko ST; Yip WWK; Young AL; Tham CC; Chen LJ; Pang CP
    JAMA; 2023 Feb; 329(6):472-481. PubMed ID: 36786791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atropine in ameliorating the progression of myopia in children with mild to moderate myopia: a meta-analysis of controlled clinical trials.
    Song YY; Wang H; Wang BS; Qi H; Rong ZX; Chen HZ
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):361-8. PubMed ID: 21649523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropicamide and myopia progression.
    Iribarren R
    Ophthalmology; 2008 Jun; 115(6):1103-4; author reply 1104. PubMed ID: 18519078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.